This report covers the markets for craniomaxillofacial (CMF) devices and the biologics used in CMF and
neurosurgical procedures including: plates and screws, bone graft substitutes, cranial flap fixation, dural
repair and temporomandibular joint (TMJ). The report also includes products used in thoracic surgery for
sternal closure as many manufacturers often group these products within their CMF portfolio.

Infusion therapy devices are used for administering fluids or medication directly into a vein. Some disease states are too severe to be treated with oral medications, and must be treated intravenously. This is generally facilitated with an intravenous (IV) bag that is connected to a catheter inserted into a vein using plastic IV tubing. Infusion can be achieved simply through gravity drip, which uses gravity to introduce fluids into a patient’s vasculature or through the use of an electronic pump. Initially, connecting tubing to the catheter inserted into the patient was done by spiking a needle into a connector on the catheter. However, due to concerns over needlestick injuries and the increased incidence of infection when infusing with non-closed systems, some markets have shifted towards the use of needle-free connectors. Physicians now have the option of connecting the tubing to the inserted catheter using male luer connections and other connectors that accept blunt cannulas.
In 2013, the Asia-Pacific market for infusion therapy devices included volumetric infusion pumps, syringe infusion pumps, disposable infusion pumps, IV tubing sets, needleless connectors and stopcocks. These categories are segmented based on the type of displacement used, the type of infusion being performed and the type of medication and fluid infused. There are several other accessories commonly used during infusion therapy, such as disinfecting caps and three-way stopcocks; however, these aren’t included in the total market value for this report.
Additionally, needleless connectors are not included in the overall market value in this chapter, as they are present only in Australia and Japan, but not in South Korea. The information for each needleless connector market can be found in each country’s respective chapter.

The full report suite on the global market for ventilators includes acute care ventilators, sub-acute care ventilators, home care ventilators, neonatal ventilators, and non-invasive ventilators.

This iteration of the report aims to analyze and evaluate the current state of the U.S. professional teeth whitening and power toothbrush markets, including existing and potential markets, product average selling prices, procedures and unit volumes.

In 2013, the European market for female neonatal diagnostic devices was valued at over €410 million. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, infant warmers and incubators. Europe’s economic climate will continue to influence the many different sectors examined in this report. Capital equipment sales will be negatively influenced by health care restraints due to economic instability; this effect will be particularly pronounced in the more pricesensitive Southern European countries.

The total vaginal speculum market for the U.K., Germany, Italy, Turkey and the Netherlands was valued at just over €4 million in 2013. In order to facilitate the gynecological or obstetric examinations, vaginal specula are often used to dilate the vaginal walls for optimal visualization. Vaginal specula are also used to increase access to the vagina and exterior of the cervix during an obstetric or gynecological procedure.

In the United States, the administration of drugs through intravenous or intramuscular injection (parenterally) has been consistently rising since the 1990s. These injections are being performed not only through the traditional method of drawing a fluid from a vial or ampoule into a syringe through a hypodermic needle at the time of administration, but also through prefilled syringes. A doctor or nurse filling a syringe just before use can be a time-consuming process that can also increase the likelihood of incorrect dosage or the patient and medical professional being exposed to a caustic or otherwise harmful substance. Prefilled syringes not only address drug and device manufacturers’ concerns about drug overfill but also customers’ increasing concerns over patient safety and increasing procedural costs. Prefilled syringes are convenient and cost-effective devices that can be easily stored and disposed of, and they increase the likelihood of the drug being sterile and having the proper dosage, which is becoming an increasingly important factor as newer high-potency, longer-lasting drugs are being used across the medical industry.

The medical aesthetics market is composed of pharmaceuticals and devices generally utilized for elective conditions and consequently, not covered by third-party providers for reimbursement. Therefore, the market is exceptionally susceptible to recessionary economic conditions and vulnerable to the contraction of credit. In 2012, the European economic continues to slump following the recession of 2008 and 2009, a number of key products have weathered the decline and have retained a healthy growth rate. Significant demand and name-brand recognition have been able to drive sales through this period, providing a more cost-efficient alternative to more expensive treatments, leading to a general marketing trend focused on affordability and minimally invasive products, rather than more dramatic and expensive surgical substitutes.

The orthopedic large joint reconstruction device market includes hip reconstruction devices, knee reconstruction devices and bone cements used to help adhere the implants to bone. Large joint arthroplasty experienced a continued increase in demand in 2012, attributed to the aging Brazilian population and an increased number of patients able to afford these procedures. Procedure growth will rise over the forecast period as older patients are no longer able to postpone elective joint replacement. Hip reconstruction market growth will continue to outpace knee reconstruction market growth throughout the forecast period. Both the knee and hip markets experienced a steep increase in growth in 2012, as more orthopedic products continued to be introduced into Brazil. Unit volumes will continue to grow steadily over the forecast period due to the growing demand for arthroplasty.

The Brazilian small bone & joint orthopedic market is comprised of the shoulder reconstruction, elbow repair, hand & wrist devices and foot & ankle devices market segments. This market is separate from the large joint and trauma markets, although the distinction is sometimes unclear. As a result, defining small joint devices can be challenging. Similar to large joints, many of the small joint devices are involved in elective procedures, and consequently these devices generally command higher selling prices. Conversely, the small joint device market is also similar to the trauma device market, where devices may not have high prices or significant price growth, but are involved in essential surgery and are always in demand. Small joints such as shoulders, elbows, hands and feet have not received as much attention as hip and knee treatments until recently, but have experienced strong and consistent growth because of the clinically underserved areas that they represent.

Wound and tissue management includes devices that treat wounds to the skin, dermal layer and adjacent subcutaneous tissues as well as devices that manage trauma to tissue and blood vessels during surgery. Wound management devices treat external wounds; while dressings and negative pressure wound therapy aid the body’s innate ability to heal skin wounds, surgical wounds and chronic wounds. Devices used for tissue management help to stop bleeding, close surgical incision and prevent scarring and adhesion of internal tissue. Wound closure devices hold tissue together so the body can develop scar tissue. Wound and tissue management products and devices are essential in an early or later phase for the proper healing of tissue and wounds.

In 2011, the market for dental instruments, hygiene and oral care equipment and disposables in Europe
was valued at over €519 million.The European markets for dental growth factors include the markets for emdogain, in addition to the markets for potential dental growth factors such as GEM-21S and INFUSE and Platelet Rich Plasma (PRP) This market includes dental turbines, electric dental handpieces, dental burs, dental scalers, dental lasers,
prophylaxis angles and pastes, professional teeth whitening products, professional fluoride products and
digital caries detection devices. The dental products and instruments covered in this report span a range of
clinical indications and mainly target private dental practices. Driven by the increasing number of dentists
and dental hygienists being trained and the rise in the use of cosmetic dentistry devices, the market is
expected to increase at a steady rate for the foreseeable future. Scope: forecast period over the next 5 years (2012 – 2017) Report Includes: Competitor Analysis: We provide a detailed analysis of the competative landscape including market shares and qualitative discussions of the leading and upcoming competitors in each market segment. Identify Strategic Opportunities, Customer Feedback and Market Monitoring, Market Overview by Segment & Country, Trend Analysis by Segment & Country, Market Drivers & Limiters, Mergers & Acqusitions. Segments included: Scope:Report covers 15 countries including Germany, France, U.K, Italy, Spain, Benelux, Scandinavia, Austria, Switzerland, Portugal. Segments included: DENTAL TURBINES, ELECTRIC DENTAL HANDPIECE DEVICES, DENTAL HANDPIECE BURS, DENTAL SCALERS, DENTAL LASER, DIGITAL CARIES DETECTION,PROPHYLAXIS ANGLE AND CUP,PROPHYLAXIS PASTE,PROFESSIONAL FLUORIDE,PROFESSIONAL TEETH WHITENING.

The U.S. bracing and supports market includes knee bracing and supports, ankle bracing and supports, spinal orthoses, back soft goods, upper extremity bracing and soft goods and pain management (including cold therapy and pain infusion pumps). Most of these markets are expected to experience slow to moderate growth because of an aging U.S. population, growing prevalence of obesity and osteoarthritis and increasing use of braces as prophylaxis to prevent sporting injuries. The knee bracing and supports market is expected to remain the largest segment, but overall growth will be driven by the spinal orthosis and pain management markets. The spinal orthosis segment is particularly fast-growing due to the strong correlation between an aging population and the incidence of lower back problems that may require spinal orthoses to prevent further injury or control stability post-surgery.

The dental implant and final abutment market includes dental implants, final abutments, instrument kits, computer guided surgery equipment and mini implants. Dental implants represented nearly 58% of the total market in 2011. The overall market is expected to grow as the economic recovery experienced in 2010 carries over into 2011. The instrument kit market comprised only a small fraction of the total market as the majority of kits were given away for free as promotional tools. While the computer guided surgery market also comprised a small portion of the total market, it is expected to grow rapidly due to recent technological advancements in digital imaging systems. These systems are becoming a popular tool among dentists and offer enhanced accuracy in placing implants. Mini implants are one of the fastest-growing segments in the total market, and is largely driven by the increasing popularity of overdentures.

This market includes air driven dental handpieces, electric dental handpieces, ultrasonic scalers, dental lasers, prophylaxis angles and prophylaxis pastes, professional teeth whitening products, oral irrigators, dental guards, professional fluoride products and digital caries detection devices. The dental products and instruments covered in this report span a range of clinical indications and mainly target private dental practices.

Medical aesthetic devices are generally used for conditions that are elective and, consequently, are not reimbursed by third-party providers. This has resulted in a market that is vulnerable to decline during recessionary economic conditions. However,
a number of key products have significant demand and brand name recognition, which has driven sales through this period. The medical devices and pharmaceuticals discussed in this report span a wide range of indications and target consumers; this provides a number of alternative treatments at various price points for consumers to choose from. During the recession of 2008 and 2009, the more affordable procedures generally fared better than more expensive treatments. The same was also true for treatments that were minimally invasive compared to surgical alternatives. Medical aesthetic treatments are varied and the products evolve at a faster pace than what is typically seen in other medical device markets.